IV Set Bought for ₹11, MRP ₹325: Maharashtra FDA Raises Concern
In July 2026, the Maharashtra Food and Drug Administration (FDA) checked the prices of hospital consumables in the Mumbai Metropolitan Region (MMR), Pune and Chhatrapati Sambhajinagar. Bills from around 20–25 hospitals were examined.
The FDA found a big difference between the purchase price and the printed MRP of some hospital consumables. For example, an IV infusion set was purchased for ₹11.05, but its printed MRP was ₹325. A syringe was purchased for ₹6.75 and had an MRP of ₹57.20, while a catheter purchased for ₹29.41 had an MRP of ₹310. The FDA also reported margins of around 200–300% for some consumables.
The FDA sent its findings to the National Pharmaceutical Pricing Authority (NPPA) in the first week of August. It suggested reviewing the difference between the purchase price and MRP and proposed bringing frequently used and essential hospital consumables and medical devices under price control.
The FDA also clarified that it cannot control hospital admission or procedure charges. Its role in this matter is to raise the pricing issue with the NPPA, which is the authority that can regulate these prices.
Source: The Indian Express – IV set bought for Rs 11, sold with Rs 325 MRP: Maharashtra FDA seeks price caps
Do you think patients should have more transparency about the prices of hospital consumables, along with hospital and medicine charges?
MBH/AB